(firstQuint)A Study to Assess the Safety and Efficacy of ASP1941 in Combination With -glucosidase Inhibitor in Type 2 Diabetic Patients.

 This is a 52-week multi-center study in subjects with type 2 diabetes mellitus who have inadequate glycemic control on an -Glucosidase Inhibitor alone.

 Dosage may be increased during the treatment period if subjects fulfill increasing criteria and the investigators adjudicate that no impact for subjects safety.

.

 A Study to Assess the Safety and Efficacy of ASP1941 in Combination With -glucosidase Inhibitor in Type 2 Diabetic Patients@highlight

This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and -glucosidase inhibitor in Japanese patients with type 2 diabetes mellitus.

